Abstract
Common drugs of misuse include alcohol, nicotine (and tobacco products), cannabis, cocaine and, to a certain extent, caffeine. Other lesser used drugs include amphetamines, opiates, sedatives/hypnotics, phencyclidines, hallucinogens and anabolic steroids. In Europe there are many millions of drug misusers and, similarly, the extent of drug misuse in North America is staggering. Thus, in the UK there are between 1 and 3 million alcohol abusers and a third of the adult population smoke tobacco products. The biomedical implications of this prevalence are considerable. In comparison with psychomotor, neuropsychiatric and cognitive reports on the above substances, investigations into organ damage are comparatively limited. This particularly relates to the biochemical mechanisms responsible for tissue specific lesions. It is a truism that virtually every single tissue system or organ in the mammalian body is adversely affected to some degree by one or more of the above drugs of misuse. At the extreme, there is organ failure and death. At the very least, there may arise compensatory mechanisms, that may be considered to be either adaptive or destructive but, nevertheless, impair organ function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Notes
C. S. Lieber, ‘The Metabolism of Alcohol and its Implication for the Pathogenesis of Disease’, in V. R. Preedy and R. R. Watson (eds), Biological Mechanisms in Disease: Alcohol and the Gastrointestinal Tract (Boca Raton: CRC Press, 1995).
V. R. Preedy, T. J. Peters, V. B. Patel and J. P. Miell, ‘Chronic Alcoholic Myopathy: Transcription and Translational Alterations’, FASEB Journal, 8 (1994): 1146–51.
K. Tunving, ‘Fatal Outcome in Drug Addiction’, Acta Psychiatrica Scandinavica, 77 (1988): 551–66.
V. R. Preedy, T. Siddiq, H. J. F. Why and P. J. Richardson, ‘Ethanol Toxicity and Cardiac Protein Synthesis in vivo’, American Heart Journal, 127 (1994): 1432–9.
A. Rosengren, L. Wilhelmsen and H. Wedel, ‘Separate and Combined Effects of Smoking and Alcohol Abuse in Middle-aged Men’, Acta Medica Scandinavica, 223 (1988): 111–8.
D. Lam and N. Goldschlager, ‘Myocardial Injury Associated with Polysubstance Abuse’, American Heart Journal, 115 (1988): 675–80.
R. Doll, R. Peto, K. Wheatley, R. Gray and I. Sutherland, ‘Mortality in Relation to Smoking: 40 years’ Observation on Male British Doctors’, British Medical Journal, 309 (1994): 901–11.
M. D. Winniford, K. R. Wheelan, M. S. Kremers, V. Ugolini, E. Vanden-Berg Jr, E. H. Niggermann, D. E. Jansen and L. D. Hillis, ‘Smoking-Induced Coronary Vasoconstriction in Patients with Atherosclerotic Coronary Artery Disease: Evidence for Adrenergically Mediated Alterations in Coronary Artery Tone’, Circulation, 73 (1986): 662–7.
D. W. Kaufman, S. P. Helmrich, L. Rosenberg, O. S. Miettinen and S. Shapiro, ‘Nicotine and Carbon Monoxide Content of Cigarette Smoke and the Risk of Myocardial Infarction in Young Men’, New England Journal of Medicine, 308 (1983): 409–13.
J. B. Saunders, D. G. Beevers and A. Paton, ‘Factors Influencing Blood Pressure in Chronic Alcoholics’, Clinical Science, 57 (1979): 295S – 298S.
J. A. Cauley, L. H. Kuller, R. E. LaPorte, W. S. Dai and J. A. D’Antonio, ‘Studies on the Association Between Alcohol and High Density Lipoprotein Cholesterol: Possible Benefits and Risks’, Advances in Alcohol and Substance Abuse, 6 (1987): 53–67.
V. R. Preedy and P. J. Richardson, ‘Ethanol-induced Cardiovascular Disease’, British Medical Bulletin, 50 (1994): 152–63.
H. S. Friedman, ‘Cardiovascular Effects of Ethanol’, in C. S. Lieber (ed.), Medical and Nutritional Complications of Alcoholism. Mechanisms and Management (New York: Plenum, 1992), pp. 359–401.
D. McCall, ‘Alcohol and the Cardiovascular System’, Current Problems in Cardiology, 12 (1987): 353–401.
V. R. Preedy, T. Siddiq, H. J. F. Why and P. J. Richardson, ‘The Deleterious Effects of Alcohol on the Heart: Involvement of Protein Turnover’, Alcohol and Alcoholism, 29 (1994): 141–7.
R. Doll, R. Peto, E. Hall, K. Wheatley and R. Gray, ‘Mortality in Relation to Consumption of Alcohol: 13 years’ Observations on Male British Doctors’, British Medical Journal, 309 (1994): 911–8.
P. J. Richardson, and A. D. Wodak, ‘Alcohol-induced Heart Muscle Disease’, in C. Symons, T. Evans and A. G. Mitchell (eds), Specific Heart Muscle Disease (Bristol: Wright PSG), 99–122.
V. R. Preedy, L. M. Atkinson, P. J. Richardson and T. J. Peters, ‘Mechanisms of Ethanol-induced Cardiac Damage’, British Heart Journal, 69 (1993): 197–200.
J. L. Martinez and M. Penna, ‘Influence of Changes in Calcium Concentration and Verapamil on the Cardiac Depressant Effect of Ethanol in Cat Papillary Muscle’, General Pharmacology, 23 (1992): 1051–6.
P. J. Richardson, A. D. Wodak, L. Atkinson, J. B. Saunders and D. E. Jewitt, ‘Relation between Alcohol Intake, Myocardial Enzyme Activity, and Myocardial Function in Dilated Cardiomyopathy’, British Heart Journal, 56 (1986): 165–70.
L. A. Reinke, E. K. Lai, C. M. DuBose and P. B. McCay, ‘Reactive Free Radical Generation in vivo in Heart and Liver of Ethanol-fed Rats: Correlation with Radical Formation in vitro’, Proceedings of the National Academy of Sciences USA, 84 (1987): 9223–7.
A. A. Welder, L. J. Dickson and R. B. Melchert, ‘Cocaethylene Toxicity in Rat Primary Myocardial Cell Cultures’, Alcohol, 10 (1993): 285–90.
M. Fane, R. de-la-Tone, M. Llorente, X. Lamas, B. Ugena, J. Segura and J. Cami, ‘Alcohol and Cocaine Interactions of Humans’, Journal of Pharmacology and Experimental Therapeutics, 266 (1993): 1364–73.
R. A. Kloner, S. Hale, K. Alker and S. Rezkalla, ‘The Effects of Acute and Chronic Cocaine Use on the Heart’, Circulation, 85 (1992): 407–19.
G. Nahas, R. Trouve, W. Manger and C. Latour, ‘Cocaine and Sympathoadrenal System’, Advances in Bioscience, 80 (1991): 151–64.
G. E. Billman, ‘Mechanisms Responsible for the Cardiovascular Effects of Cocaine’, FASEB Journal, 4 (1990): 2469–75.
K. Kumor, M. Sherer, L. Thompson, E. Cone, J. Mahaffey and J. H. Jaffe, ‘Lack of Cardiovascular Tolerance during Intravenous Cocaine Infusions in Human Volunteers’, Life-Sciences, 42 (1988): 2063–71.
T. D. Fraker, P. N. Temesy-Armos, P. S. Brewster and R. D. Wilkerson, ‘Mechanism of Cocaine-induced Myocardial Depression in Dogs’, Circulation, 81 (1990): 1012–6.
S. L. Hale, K. J. Alker, S. Rezkalla, G. Figures and R. A. Kloner, ‘Adverse Effects of Cocaine in Cardiovascular Dynamics, Myocardial Blood Flow, and Coronary Artery Diameter in an Experimental Model’, American Heart Journal, 118 (1989): 927–33.
M. E. Trulson, L. R. Epps, and J. C. Joe, ‘Cocaine: Long term Administration Depletes Cardiac Cellular Enzymes in the Rat’, Acta Anatomica, 129 (1987): 165–8.
F. D. Kolodgie, R. Virmani, H. E. Rice, E. E. Hederick and W. J. Mergner, ‘Intravenous Cocaine Accelerates Atherosclerosis in Cholesterol-fed New Zealand White Rabbits’, Journal of the American College of Cardiology, 15 (1990): 217A.
R. A. Lange, R. G. Cigarroa, C. W. Yancy, J. E. Willard, J. J. Popma, M. N. Sills, W. McBride, A. S. Kim and L. D. Hillis, ‘Cocaine-induced Coronary-Artery Vasoconstriction’, New England Journal of Medicine, 321 (1989): 1557–62.
E. D. Flores, R. A. Lange, R. G. Cigarroa and L. D. Hillis, ‘Effect of Cocaine on Coronary Artery Dimensions in Atherosclerotic Coronary Artery Disease: Enhanced Vasoconstriction at Sites of Significant Stenosis’, Journal of the American College of Cardiology, 16 (1990): 74–9.
S. K. Chokshi, D. Gal, S. DeJesus and J. M. Isner, ‘Cocaine Produces Vasoconstriction of Human Coronary Arteries: In Vitro Studies using Coronary Arteries Obtained from Freshly Explanted Human Hearts’, Journal of the American College of Cardiology, 15 (1990): 215A.
F. H. Zimmerman, G. M. Gustafson and H. G. Kemp, ‘Recurrent Myocardial Infarction Associated with Cocaine Abuse in a Young Man with Normal Coronary Arteries: Evidence for Coronary artery spasm culminating in thrombosis’, Journal of the American College of Cardiology, 9 (1987): 9648.
F. A. Dressler, S. Malekzadeh and W. C. Roberts, ‘Quantitative Analysis of Amounts of Coronary Arterial Narrowing in Cocaine Addicts’, American Journal of Cardiology, 65 (1990): 303–8.
B. D. Bertolet, G. Freund, C. A. Martin, D. L. Perchalski, C. M. Williams and C. J. Pepine, ‘Unrecognised Left Ventricular Dysfunction in an Apparently Healthy Cocaine Abuse Population’, Clinical Cardiology, 13 (1990): 323–8.
R. Virmani, M. Robinowitz, J. E. Smialek and D. F. Smyth, ‘Cardiovascular Effects of Cocaine: An Autopsy Study of 40 Patients’, American Heart Journal, 115 (1988): 1068–76.
S. K. Peng, W. J. French and P. C. Pelikan, ‘Direct Cocaine Cardiotoxicity Demonstrated by Endomyocardial Biopsy’, Archives of Pathology and Laboratory Medecine, 113 (1989): 842–5.
R. G. Stenberg, M. D. Winniford, L. D. Hillis, G. P. Dowling and L. M. Buja, ‘Simultaneous Acute Thrombosis of Two Major Coronary Arteries Following Intravenous Cocaine Use’, Archives of Pathology and Laboratory Medecine, 113 (1989): 521–4.
K. R. Petronis and J. C. Anthony, ‘An Epidemiologic Investigation of Marijuana and Cocaine-related Palpitations’, Drug and Alcohol Dependence, 23 (1989): 219–26.
T. K. Leonard, R. R. Watson and M. E. Mohs, ‘The Effects of Caffeine on Various Body Systems: A Review’, Journal of the American Dietician Association, 87 (1987): 1048–53.
A. Varro, S. Hester and J. G. Papp, ‘Caffeine-induced Decreases in the Inward Rectifier Potassium and the Inward Calcium Currents in Rat Ventricular Myocytes’, British Journal of Pharmacology, 109 (1993): 895–7.
C. J. Duncan, ‘Role of Calcium in Triggering Rapid Ultrastructural Damage in Muscle: A Study with Chemically Skinned Fibres’, Journal of Cell Science, 87 (1987): 581–94.
S. Daniels and C. J. Duncan, ‘Cellular Damage in the Rat Heart caused by Caffeine or Dinitrophenol’, Comparative Biochemistry and Physiology C, 105 (1993): 225–9.
P. Smits, L. Temme and T. Thien, ‘The Cardiovascular Interaction between Caffeine and Nicotine in Humans’, Clinical Pharmacology and Therapeutics, 54 (1993): 194–204.
P. Bonazzola and J. E. Ponce-Homos, ‘Effects of Caffeine on Energy Output of Rabbit Heart Muscle’, Basic Research in Cardiology, 82 (1987): 428–36.
P. W. Wilson, R. J. Garrison, W. B. Kannel, et al., ‘Is Coffee Consumption a Contribution to Cardiovascular Disease? Insights from the Framingham Study’, Archives of Internal Medicine, 149 (1989): 1169–72.
M. Matsuzaki, G. A. Casella, and M. Ratner, ‘Delta 9-Tetrahydrocannabinol: EEG Changes, Bradycardia and Hypothermia in the Rhesus Monkey’, Brain Research Bulletin, 19 (1987): 223–9.
J. G. Bernstein, ‘Medical Consequences of Marijuana use’, in N. K. Mello (ed.), Advances in Substance Abuse, Behavioral and Biological Research (Greenwich: JAI Press, 1980), pp. 255–88.
C. H. Ashton, ‘Solvent Abuse: Little Progress after 20 Years’, British Medical Journal, 300 (1990): 135–6.
J. Ramsey, H. R. Anderson, K. Bloor and R. J. Flanagan, ‘An Introduction to the Practice, Prevalence and Chemical Toxicology of Volatile Substance Abuse’, Human Toxicology, 8 (1989): 261–9.
S. M. Claydon, ‘Myocardial Degeneration in Chronic Solvent Abuse’, Medicine Science and the Law, 28 (1988): 217–8.
M. Bass, ‘Sudden Sniffing Death’, Journal of the American Medical Association, 212 (1970): 2075–9.
D. W. Nierenberg, M. B. Horowitz, K. M. Harris and D. H. James, ‘Mineral Spirits Inhalation Associated with Hemolysis, Pulmonary Edema and Ventricular Fibrillation’, Archives of Internal Medicine, 151 (1991): 1437–40.
C. F. Reinhardt, A. Azar, M. E. Maxfield, P. E. Smith and L. S. Mullin, ‘Cardiac Arrhythmias and Aerosol “Sniffing”’, Archives of Environmental Health, 22 (1971): 265–79.
R. M. Wodka and E. W. Jeong, ‘Cardiac Effects of Inhaled Typewriter Correction Fluid’, Annals of Internal Medicine, 110 (1989): 91–2.
S. R. Cunningham, G. W. N. Dalzell, P. McGirr and M. M. Khan, ‘Myocardial Infarction and Primary Ventricular Fibrillation after Glue Sniffing’, British Medical Journal, 294 (1987): 739–40.
Editor information
Editors and Affiliations
Copyright information
© 1996 Adrian Bonner and James Waterhouse
About this chapter
Cite this chapter
Preedy, V.R., Why, H., Patel, V., Bonner, A., Richardson, P. (1996). Substance Misuse and Tissue Pathology with Special Reference to the Heart. In: Bonner, A., Waterhouse, J. (eds) Addictive Behaviour: Molecules to Mankind. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-24657-1_6
Download citation
DOI: https://doi.org/10.1007/978-1-349-24657-1_6
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-0-333-64556-7
Online ISBN: 978-1-349-24657-1
eBook Packages: Palgrave Social & Cultural Studies CollectionSocial Sciences (R0)